HCA Healthcare (NYSE:HCA) Price Target Raised to $400.00

HCA Healthcare (NYSE:HCA) had its price objective upped by Oppenheimer from $390.00 to $400.00 in a report issued on Monday, Benzinga reports. They currently have an outperform rating on the stock.

Several other brokerages have also recently issued reports on HCA. Leerink Partners boosted their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. UBS Group boosted their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Royal Bank of Canada boosted their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Morgan Stanley initiated coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Finally, Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $365.00 to $395.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 22nd. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $379.11.

HCA Healthcare Price Performance

HCA stock opened at $358.57 on Monday. The firm’s 50-day moving average price is $393.62 and its two-hundred day moving average price is $353.85. HCA Healthcare has a 12-month low of $223.73 and a 12-month high of $417.14. The stock has a market capitalization of $92.54 billion, a price-to-earnings ratio of 16.10, a PEG ratio of 1.52 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is presently 11.85%.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth about $27,000. Unique Wealth Strategies LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth about $28,000. GPS Wealth Strategies Group LLC lifted its position in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new stake in shares of HCA Healthcare during the second quarter worth about $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.